Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

doi:10.3748/wjg.v28.i23.2597

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5404)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

303

WORD

HTML

2126

Figures (1-2)

409

Tables (1-3)

330

Sum=3254

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

238

Download

452

Sum=690

Publishing Process of This Article

Item

Count

Browse

370

Download

1090

Sum=1460

Jun 21, 2022 (publication date) through Jun 17, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 21, 2022; 28(23): 2597-2608
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2597

Full Size Figure Download Figure

Figure 1 Correlation between serum trough level of infliximab, adalimumab and fistula healing. A: Infliximab; B: Adalimumab.

Citation: Gu B, Venkatesh K, Williams AJ, Ng W, Corte C, Gholamrezaei A, Ghaly S, Xuan W, Paramsothy S, Connor S. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease. World J Gastroenterol 2022; 28(23): 2597-2608
URL: https://www.wjgnet.com/1007-9327/full/v28/i23/2597.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i23.2597